The Latest Diabetes Industry Statistics Explained
The global diabetes devices market was worth USD 31.6 billion in 2019.
The statistic ‘The global diabetes devices market was worth USD 31.6 billion in 2019’ indicates the total value of medical devices specifically designed for diabetes management and monitoring sold worldwide in the year 2019. This encompasses a wide range of products including glucose meters, continuous glucose monitoring systems, insulin pumps, insulin pens, and other related devices. The size of the market reflects the significant demand for diabetes management solutions driven by the increasing prevalence of diabetes globally, advancements in technology, and growing awareness about the importance of effectively managing this chronic condition. The figure of USD 31.6 billion underscores the economic importance and market potential within the diabetes healthcare sector.
The global diabetes devices market is expected to expand at a CAGR of 7.1% from 2020 to 2027.
This statistic indicates that the global diabetes devices market is projected to grow steadily at a Compound Annual Growth Rate (CAGR) of 7.1% from 2020 to 2027. This implies that the market for diabetes devices, including glucose monitoring systems, insulin delivery devices, and other related products, is expected to increase in value by an average annual rate of 7.1% over the specified period. This growth rate suggests a positive outlook for the industry, driven by factors such as the rising prevalence of diabetes worldwide, technological advancements in diabetes management devices, and an increasing focus on preventive healthcare measures. Investors, manufacturers, healthcare providers, and other stakeholders in the diabetes market can use this information to make informed decisions regarding resource allocation, product development, market strategies, and overall business planning.
North America captured the highest market share in 2018, and it is expected to maintain its lead over the forecast period.
The statistic indicates that North America had the largest market share among all regions in 2018, suggesting that it held the largest portion of sales or revenue within a particular industry or market during that year. Additionally, the statement implies that North America is predicted to continue leading in market share over the forecast period, indicating that it is expected to maintain its dominance and potentially even increase its share compared to other regions. This forecast could be driven by various factors, such as the region’s economic stability, technological advancements, consumer demand, or competitive landscape. Overall, the statement highlights North America as a key player in the market and indicates its sustained importance in the industry going forward.
Over 5 million people in the UK are expected to have diabetes by 2025.
The statistic “Over 5 million people in the UK are expected to have diabetes by 2025” highlights the significant and concerning trend of rising diabetes prevalence in the UK. This projection suggests a substantial increase in the number of individuals living with diabetes, indicating a pressing public health issue that requires attention and intervention. The statistic serves as a stark reminder of the growing burden of chronic diseases such as diabetes on individuals, healthcare systems, and society as a whole. It underscores the urgent need for preventive measures, education, and policies aimed at reducing the risk factors associated with diabetes and improving management strategies to curb the escalating diabetes epidemic in the UK.
In 2020, there were 463 million people worldwide with diabetes.
The statistic that in 2020, there were 463 million people worldwide with diabetes represents the estimated number of individuals globally who were diagnosed with diabetes during that year. Diabetes is a chronic condition characterized by high levels of glucose in the blood, either due to insufficient insulin production or the body’s inability to effectively use insulin. This statistic underscores the significant and growing public health concern posed by diabetes, with a large number of individuals impacted by the condition across various regions and populations. Effective management of diabetes through lifestyle modifications, medication, and healthcare interventions is crucial to reduce the burden of the disease on individuals and healthcare systems worldwide.
The global diabetes care devices market is expected to reach USD 39.83 billion by 2026.
The statistic implies that the global market for diabetes care devices, including products such as glucose monitoring systems, insulin delivery devices, and continuous glucose monitors, is projected to grow significantly and reach a value of USD 39.83 billion by the year 2026. This indicates a substantial increase in demand for devices aimed at managing diabetes, likely due to factors such as a rise in the prevalence of diabetes worldwide, technological advancements in diabetes care products, and increasing awareness about the importance of proper diabetes management. The market is expected to continue expanding as the need for effective diabetes management solutions continues to grow.
The Asia-Pacific diabetes care devices market is anticipated to grow at the highest CAGR during 2021-2028.
The statistic indicates that the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR) in the market for diabetes care devices between the years 2021 and 2028. This suggests a significant uptrend in demand and consumption of diabetes care devices within the Asia-Pacific region compared to other regions during this time period. Factors driving this growth could include increasing prevalence of diabetes, rising awareness and focus on healthcare, improving healthcare infrastructure, and advancements in diabetes care technologies. This statistic highlights the potential opportunities for market expansion and investment in the diabetes care devices sector in the Asia-Pacific region over the next few years.
In 2020, the direct cost of treating diabetes globally was estimated at USD 825 billion.
The statistic that in 2020, the direct cost of treating diabetes globally was estimated at USD 825 billion indicates the substantial financial burden that diabetes imposes on healthcare systems around the world. This figure represents the total expenses incurred for medical treatments, medications, hospitalizations, and other healthcare services directly related to managing diabetes. The high cost highlights the significant impact of diabetes on both individuals and society, underscoring the importance of early prevention, effective management, and investment in healthcare resources to alleviate the economic strain associated with this chronic condition.
Pen needles dominated 37.6% of the diabetes care devices market in 2018.
This statistic indicates that pen needles accounted for 37.6% of the total market share within the diabetes care devices market in 2018. Pen needles are a common device used by individuals with diabetes to administer insulin injections, and their significant market domination highlights their importance within the diabetes care landscape during that year. The high market share of pen needles suggests their widespread use and acceptance among individuals with diabetes, healthcare providers, and other stakeholders involved in the management of diabetes. This statistic underscores the crucial role that pen needles play in the delivery of care for individuals living with diabetes, emphasizing their prominent position within the diabetes care devices market in 2018.
Type 2 diabetes held over 85% market share in the types of diabetes segment in 2019.
This statistic indicates that among all types of diabetes, Type 2 diabetes dominated the market share in 2019, accounting for over 85% of all cases. This suggests that Type 2 diabetes is the most prevalent form of diabetes in the segment, significantly outweighing other types such as Type 1 or gestational diabetes. The high market share of Type 2 diabetes underscores its widespread occurrence and may reflect factors such as lifestyle and dietary habits, genetics, and aging population trends that contribute to the prevalence of this type of diabetes in the population. Healthcare professionals and policymakers may use this information to tailor prevention and treatment strategies to address the significant burden of Type 2 diabetes within the diabetic population.
In 2019, the diabetes service market in the United States was worth USD 24.9 billion.
The statistic that in 2019, the diabetes service market in the United States was valued at USD 24.9 billion represents the total monetary value of products and services related to the treatment and management of diabetes within the country for that year. This figure encompasses a wide range of services, including medication, medical devices, diagnostics, patient education, and other healthcare services specific to diabetes care. The market value gives insight into the significant financial investment and economic activity associated with addressing the healthcare needs of individuals with diabetes in the US, reflecting the scale and importance of this market segment within the broader healthcare industry.
As of 2017, 10.5% of the U.S. population, or 34.2 million people, had diabetes.
The statistic provided indicates that as of 2017, approximately 10.5% of the United States population, totaling 34.2 million individuals, were diagnosed with diabetes. This high prevalence indicates a significant public health concern, as diabetes is a chronic condition that can have serious health implications if not managed properly. The statistic serves as a stark reminder of the importance of promoting healthy lifestyles, increasing awareness about diabetes prevention and management, and ensuring accessible healthcare services for individuals with diabetes. The large number of people affected also highlights the need for continued research, education, and support to address the growing burden of diabetes in the U.S. population.
By 2030, the number of people with diabetes is expected to rise to 578 million.
The statistic that by 2030, the number of people with diabetes is expected to rise to 578 million highlights the alarming global trend of increasing prevalence of diabetes. This projection signifies a substantial rise in the number of individuals worldwide affected by the chronic condition, which can have significant health, social, and economic implications. The increasing prevalence of diabetes is concerning due to its association with various complications such as cardiovascular diseases, kidney failure, and vision impairment. It underscores the importance of public health interventions, lifestyle modifications, and improved access to healthcare services to effectively manage and prevent diabetes on a global scale.
As of 2021, China has the highest number of people with diabetes, reaching 116.4 million.
The statistic states that as of 2021, China has the highest number of individuals diagnosed with diabetes, totaling 116.4 million. This data point highlights the significant public health challenge posed by diabetes in China, with a large segment of the population affected by the condition. The high prevalence of diabetes in China can be attributed to factors such as urbanization, changing dietary habits, sedentary lifestyles, and an aging population. The statistic underscores the importance of implementing effective public health strategies and interventions to address the growing burden of diabetes in China and prevent its associated complications.
The prevalence of diabetes in adults worldwide has risen from 4.7% in 1980 to 8.5% in 2019.
The statistic indicates that the percentage of adults worldwide diagnosed with diabetes has increased significantly over the period from 1980 to 2019, with a rise from 4.7% to 8.5%. This suggests a concerning trend of higher prevalence of diabetes, which can have serious implications for public health. Factors such as lifestyle changes, diet habits, lack of physical activity, and aging populations may have contributed to this increase. The rising prevalence of diabetes underscores the importance of preventative measures, early detection, and effective management strategies to combat the disease and its associated health risks.
The death rate from diabetes was 21.3 per 100,000 population in the U.S. in 2017.
The statistic “The death rate from diabetes was 21.3 per 100,000 population in the U.S. in 2017” indicates the number of deaths attributed to diabetes for every 100,000 individuals in the United States in the year 2017. A death rate of 21.3 per 100,000 population implies that for every 100,000 people in the U.S. in 2017, there were approximately 21.3 deaths directly caused by complications related to diabetes. This statistic serves as a measure of the impact of diabetes on mortality within the population and highlights the public health significance of the disease as a leading cause of death in the country during that year.
In 2018, the top three companies in the diabetes drug market were Novo Nordisk, Eli Lilly, and Sanofi.
The statistic states that in 2018, the top three companies dominating the diabetes drug market were Novo Nordisk, Eli Lilly, and Sanofi. This suggests that these companies held the largest market share and had the highest sales revenue for diabetes medications in that year. Given the prevalence of diabetes and the increasing demand for diabetes treatments, the fact that these three companies were the market leaders underscores their competitive strength and innovation in developing drugs to manage the disease. Furthermore, it highlights their successful marketing strategies and strong distribution networks that have enabled them to capture a significant portion of the diabetes pharmaceutical market.
By 2045, the number of people living with diabetes is expected to rise to 700 million.
The statistic that by 2045, the number of people living with diabetes is expected to rise to 700 million highlights a concerning global health trend. Diabetes is a chronic disease with serious implications for individuals’ health and well-being, as well as significant economic and social impacts on healthcare systems and societies as a whole. The projected increase to 700 million people with diabetes by 2045 underscores the urgent need for public health initiatives, improved access to healthcare services, greater awareness of diabetes prevention and management strategies, and ongoing research efforts to address this growing health challenge on a global scale.
The North American market accounted for the largest share of the global diabetes care devices market in 2020.
In 2020, the North American market held the largest proportion of the global diabetes care devices market, indicating that the region contributed the most to the overall sales and consumption of diabetes management tools and equipment worldwide. This statistic suggests that North America has a significant impact on the diabetes care industry, potentially due to factors such as high prevalence of diabetes in the region, advanced healthcare infrastructure, increased awareness, and availability of cutting-edge technologies and treatment options. The dominance of the North American market in the global diabetes care devices market in 2020 highlights the region’s substantial role in driving innovation and shaping trends within the industry.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.statista.com
2. – https://www.www.idf.org
3. – https://www.www.axiommrc.com
4. – https://www.www.who.int
5. – https://www.www.diabetes.org.uk
6. – https://www.www.cdc.gov
7. – https://www.marketsandmarkets.com
8. – https://www.www.absolutemarketsinsights.com
9. – https://www.www.diabetesatlas.org
10. – https://www.www.grandviewresearch.com
11. – https://www.www.fortunebusinessinsights.com
12. – https://www.www.transparencymarketresearch.com
